Department of Industrial Chemistry 'Toso Montanari', Alma Mater Studiorum-Università di Bologna, Viale Del Risorgimento 4, 40136 Bologna, Italy.
Department of Pharmacy and Biotechnology, University of Bologna, 40126 Bologna, Italy.
Molecules. 2022 Sep 1;27(17):5645. doi: 10.3390/molecules27175645.
A series of naphthoquinones, namely, 1,4-naphthoquinone, menadione, plumbagin, juglone, naphthazarin, and lawsone, were reacted with -acetyl--cysteine, and except for lawsone, which did not react, the related adducts were obtained. After the tuning of the solvent and reaction conditions, the reaction products were isolated as almost pure from the complex reaction mixture via simple filtration and were fully characterized. Therefore, the aim of this work was to evaluate whether the antitumor activity of new compounds of 1,4-naphthoquinone derivatives leads to an increase in ROS in tumor cell lines of cervical carcinoma (HeLa), neuroblastoma (SH-SY5Y), and osteosarcoma (SaOS2, U2OS) and in normal dermal fibroblast (HDFa). The MTT assay was used to assay cell viability, the DCF-DA fluorescent probe to evaluate ROS induction, and cell-cycle analysis to measure the antiproliferative effect. Compounds , , and showed a certain degree of cytotoxicity towards all the malignant cell lines tested, while compound showed biological activity at higher IC values. Compounds and induced increases in ROS generation after 1 h of exposure, while after 48 h of treatment, only induced an increase in ROS formation in HeLa cells. Cell-cycle analysis showed that compound caused an increase in the number of G0/G1-phase cells in the HeLa experiment, while for the U2OS and SH-SY5Y cell lines, it led to an accumulation of S-phase cells. Therefore, these novel 1,4-naphthoquinone derivatives may be useful as antitumoral agents in the treatment of different cancers.
一系列的萘醌,即 1,4-萘醌、甲萘醌、白花丹醌、胡桃醌、萘蒽醌和洛索洛芬,与 -乙酰--半胱氨酸反应,除了洛索洛芬没有反应外,得到了相关的加合物。在调整溶剂和反应条件后,通过简单的过滤从复杂的反应混合物中分离出几乎纯的反应产物,并对其进行了充分的表征。因此,本工作旨在评估 1,4-萘醌衍生物的新型化合物的抗肿瘤活性是否会导致宫颈癌细胞系(HeLa)、神经母细胞瘤(SH-SY5Y)和骨肉瘤(SaOS2、U2OS)以及正常皮肤成纤维细胞(HDFa)中 ROS 的增加。MTT 法用于检测细胞活力,DCF-DA 荧光探针用于评估 ROS 诱导,细胞周期分析用于测量抗增殖作用。化合物 、 、 对所有测试的恶性细胞系均表现出一定程度的细胞毒性,而化合物 则在更高的 IC 值下表现出生物活性。化合物 、 暴露 1 小时后诱导 ROS 生成增加,而处理 48 小时后,只有 诱导 HeLa 细胞中 ROS 形成增加。细胞周期分析表明,化合物 导致 HeLa 实验中 G0/G1 期细胞数量增加,而对于 U2OS 和 SH-SY5Y 细胞系,它导致 S 期细胞积累。因此,这些新型的 1,4-萘醌衍生物可能可作为治疗不同癌症的抗肿瘤药物。